SKYE
Skye Bioscience, Inc.
1.70$
-1.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +239.7% | +139.1% | +907.9% | -90.8% | +72.3% | +251.2% | +2.0% | +33.8% | +268.9% | -7.5% | +31.1% | +509.4% | -61.1% | |
| – | +176.8% | +190.6% | +1,019.9% | -91.9% | +98.9% | +251.5% | +2.1% | +33.6% | +260.8% | -7.0% | +30.3% | +507.9% | -61.7% | |
| – | +97.6% | +297.3% | +1,453.7% | -98.0% | +301.0% | +613.0% | -1.3% | +34.9% | +263.8% | -86.1% | +1.0% | +5,345.1% | -91.4% | |
| – | +97.6% | +297.3% | +1,453.7% | -98.0% | +301.0% | +613.0% | -1.3% | +34.9% | +263.8% | -86.1% | +1.0% | +5,345.1% | -62.4% | |
| – | +112.1% | – | – | – | – | – | – | – | – | – | +113.5% | -96.8% | +106.8% | |
| – | – | – | – | – | – | – | – | – | – | – | -98.3% | – | – | |
| – | – | – | – | – | -85.3% | +144.8% | -42.4% | +270.2% | +3,096.9% | – | – | – | – | |
| – | +4,111.6% | +340.2% | +279.1% | -41.6% | -23.5% | +1,190.8% | -91.7% | +53.3% | +79.7% | +203.7% | +16.1% | -67.2% | +79.7% | |
| – | +4,111.6% | +339.8% | -27.4% | +13.8% | +21.8% | +1,877.6% | -93.9% | -18.9% | +397.0% | +209.8% | +14.7% | -68.8% | +89.1% | |
| – | – | – | – | – | – | – | – | – | +3,111.4% | -6.3% | +130.6% | -95.9% | +4.0% | |
| – | -47.2% | +18,919.8% | -69.4% | +119.1% | -63.3% | -84.5% | +796.4% | +172.8% | +136.0% | +99.4% | -46.7% | -40.5% | +257.2% | |
| – | – | – | – | – | – | – | -71.6% | +270.4% | – | – | – | – | – | |
| – | -572.4% | – | – | -408.0% | – | – | – | -17.7% | +1,200.9% | -151.3% | – | – | -70.6% | |
| – | -40,002.6% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +22.8% | +62.5% | +16.7% | +51.6% | +335.4% | +1.2% | +74.0% | +75.7% | +242,720.5% | -99.8% | +420.8% | +8.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.